C12R2001/865

Method For Organically Planting Dendrobium

A method for organically planting Dendrobium, including using a planting medium in the epiphytic planting step of Dendrobium. The raw materials of planting medium include fermented powder of Dendrobium candidum leaves and sawdust; a method for preparing the fermented powder of Dendrobium candidum leaves is as follows: cutting Dendrobium candidum leaves into small pieces and mashing the small pieces of Dendrobium candidum leaves to obtain materials to be fermented, and then adding liquid medium to the materials to be fermented to obtain fermentation system; sterilizing the fermentation system, adding fermentation bacteria to the fermentation system to obtain a mixture, fermenting and filtering the mixture to obtain post-culturing fermentation broth and fermented products of Dendrobium candidum leaves, dewatering and crushing the fermented products of Dendrobium candidum leaves to obtain fermented powder of Dendrobium candidum leaves.

Genetically modified fungal cells for overexpression of an acetyl-CoA carboxylase and a pyruvate carboxylase

A fungal cell is capable of producing high levels of fatty acids and fatty acid-derived products. The fungal cell comprises at least one modification to the endogenous fatty acid metabolism.

Anaerobic fermentative production of furandicarboxylic acid

The present disclosure provides recombinant microorganisms and methods for the anaerobic production of 2,4-furandicarboxylic acid from one or more carbon sources. The microorganisms and methods provide redox-balanced and ATP positive pathways for co-producing 2,4-furandicarboxylic acid with ethanol and for co-producing 2,4-furandicarboxylic acid with ethanol and 1-propanol. The method provides recombinant microorganisms that express endogenous and/or exogenous nucleic acid molecules encoding polypeptides that catalyze the conversion of a carbon source into 2,4-furandicarboxylic acid and that coupled the 2,4-furandicarboxylic acid pathway with an additional metabolic pathway.

Hybrid ale yeast strain
11535823 · 2022-12-27 · ·

The invention provides a hybrid ale strain of Saccharomyces cerevisiae and uses thereof.

YEAST STRAIN PRODUCING GLUTATHIONE AND METHOD OF PRODUCING GLUTATHIONE USING THE SAME

Provided are a novel yeast strain producing glutathione and a method of producing glutathione using the same.

GENETICALLY ENGINEERED STRAIN OF SACCHAROMYCES CEREVISIAE, METHOD FOR CONSTRUCTING THE SAME AND ITS USE FOR BREWING

The present disclosure belongs to the field of bioengineering, and relates to breeding of industrial microorganisms, in particular to a genetically engineered strain of Saccharomyces cerevisiae, method for constructing the same, and its use for brewing, the genetically engineered strain of Saccharomyces cerevisiae heterogeneously overexpresses an acetaldehyde dehydrogenase gene ALD6, an acetyl-CoA synthase gene ACS1 and an alcohol acyltransferase gene AeAT9. The Saccharomyces cerevisiae strain with high yield of ethyl acetate and low yield of higher alcohols provided by the present disclosure not only maintains excellent ethanol fermentation characteristics, but also reducing the production of higher alcohols which adversely affect the comfort after drinking, which is of great significance for a well-maintained and strengthened flavor characteristics of Chinese Baijiu, an improved and stabilized quality thereof, and even a reform in the fermentation process thereof.

CRISPR EDITING IN DIPLOID GENOMES

The present disclosure relates to automated multi-module instruments, compositions and methods for performing nucleic acid-guided nuclease editing; specifically, methods, instruments, systems, and nucleic acids synthetic cassettes that improve the efficiency of gene editing using CRISPR enzymes in diploid cells—either on both chromosomes or selectively in one chromosome—without incurring loss of heterozygosity (LOH) and its often deleterious effects.

INTEGRATED DRUG DISCOVERY PLATFORM FOR PROTEIN MISFOLDING DISORDERS ASSOCIATED WITH METABOLITE ACCUMULATION
20220390471 · 2022-12-08 ·

The present disclosure provides yeast screening system/s and methods for screening of candidate therapeutic compound/s for treating, at least one proteniopathy and/or protein misfolding disorder. More specifically, the present disclosure provides systems and methods for identifying a therapeutic compound that inhibit Hcy fibril formation and uses thereof in treating Alzheimer's disease.

PROCESS FOR PRODUCING ETHANOL

The invention relates to a process for the production of ethanol, the process comprising fermenting of a carbon source composition with a recombinant yeast,

wherein the carbon source composition comprises at least glucose and arabinose; and
wherein the recombinant yeast comprises arabinose isomerase activity, ribulokinase activity, ribulose phosphate epimerase activity, glycerol uptake activity and glycerol conversion capacity; and
wherein the recombinant yeast further comprises a genetic modification leading to the reduction, downregulation, inhibition and/or elimination of the activity of a homologous protein with glycerol-efflux activity; and
wherein each of the glucose and the arabinose is converted into ethanol.

In addition, the invention relates to a recombinant yeast that can be used in such a process.

PRODUCTION OF MALONATE SEMIALDEHYDE AND DERIVATIVES BY MICROORGANISMS EXPRESSING ASPARTATE 1-DECARBOXYLASE

The present disclosure provides recombinant microorganisms and methods for producing malonate semialdehyde and/or related products, such as ketones, alcohols, organic acids, esters, alkenes, amino acids, and combinations thereof including 3-hydroxypropionic acid, acrylic acid, propionic acid, 1-propanol, acetone, 2-propanol, butanone, 1-butanol, 2-butanol, methyl propionate, 1,3-propanediol, isoamyl alcohol, 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, lactic acid, adipic acid, glutamic acid, itaconic acid, ethyl acetate, isopropyl acetate, acetic acid, butyric acid, caproic acid, citric acid, methacrylic acid, succinic acid, propylene, butadiene, ethanol, isoprenol, leucine, isoleucine, glutamine, glycine, and isoprene, from β-alanine. The recombinant microorganism expresses an asparate 1-decarboxylase that catalyzes the production of malonate semialdehyde from β-alanine.